What’s a suspension ?
Suspension Requirements?
Why a suspension?
Stability;
HOW TO MAKE A FINE POWDER? (10-50 MICRON)
Fluid Energy
Preparing Flocculated suspensions
Formulation considerations for orally administered suspension:
Rheology
Rheology for Pharmacists
Excipients used in the formulation of suspensions for oral administration:
Excipients used in the formulation of suspensions for oral administration:
Some subdosage forms of suspensions
Extemporaneous Prepration:
a suspension is a heterogeneous mixture containing solid particles that are sufficiently large for sedimentation. Usually they must be larger than one micrometer. A suspension is a heterogeneous mixture in which the solute particles do not dissolve but get suspended throughout the bulk of the medium.
Pharmaceutical Suspensions Brief Presentation on Definition, Classification of suspension, Sedimentation, Brownian movement, Electro kinetic Properties of suspension, Stability of suspensions, Formulation of Suspensions, Preparation of Suspensions, Quality control of Suspensions, Recent Advancement in Suspensions
a suspension is a heterogeneous mixture containing solid particles that are sufficiently large for sedimentation. Usually they must be larger than one micrometer. A suspension is a heterogeneous mixture in which the solute particles do not dissolve but get suspended throughout the bulk of the medium.
Pharmaceutical Suspensions Brief Presentation on Definition, Classification of suspension, Sedimentation, Brownian movement, Electro kinetic Properties of suspension, Stability of suspensions, Formulation of Suspensions, Preparation of Suspensions, Quality control of Suspensions, Recent Advancement in Suspensions
Suspension is made of two phase system, consisting of a finely divided solid particles (Dispersed phase) distributed in a particular manner throughout another medium (Continuous phase).
Comparison of time domain techniques for the evaluation of the response and t...Franco Bontempi
Plenary Lecture at Fourth M.I.T. Conference on Computational Fluid and Solid Mechanics – Focus: Fluid-Structure Interactions, Boston, June 13-15, 2007.
During the last decades, several studies on suspension bridges under wind actions have been developed in civil engineering and many techniques have been used to approach this structural problem both in time and frequency domain. In this paper, four types of time domain techniques to evaluate the response and the stability of a long span suspension bridge are implemented: nonaeroelastic, steady, quasi steady, modified quasi steady. These techniques are compared considering both nonturbulent and turbulent flow wind modelling. The results show consistent differences both in the amplitude of the response and in the value of critical wind velocity.
Physical Characterization of a Method for Production of High Stability Suspen...Editor IJCATR
Suspensions/Dispersions are encountered in a wide range of
applications, e.g., liquid abrasive cleaners, ceramics, medicines,
inks, paints….etc. In most cases it is necessary to keep the
suspension stable for the product lifetime. A new modified
differential sedimentation measuring system is suggested and used
to identify physical parameters affecting the sedimentation in
suspensions. The technique is discussed in details. It is found that
particle sizes as well as viscosity of continuous phase are the most
important factors governing the stability of a suspension. Empirical
relations are extracted to quantitatively describe the weight effect of
each factor. The modified measuring system shows good accuracy
enough to detect fluctuations in concentration of suspended
particles due to their Brownian diffusion, as well as the particles
concentrations in the stable suspension. This study confirmed the
fact that particles diameters measured by Zetasizer are much
greater than those measured by the transmission electron
microscope. This study presents a proposal for new technique for
particle size separation based on the differential sedimentation in
viscose fluids. This new method is a differential viscosity column.
The proposed size separation technique may help to separate
engineered nano-particles with higher resolution
Lung carcinogenesis by tobacco smoke - Arabic presentationHaçan Elhalabi
Lung Carcinogenesis by Tobacco Smoke
أهداف العرض التقديمي
عرض مكونات الدخان ودورها في السرطان.
آليات التأثير على المادة الوراثية وإحداث السرطان.
العلائم الحيوية الدالة على المواد المسرطنة (مراقبة).
تقديم الدلائل للمدخنين على خطورة الإقدام على التدخين (وقاية).
التدخين
الآليّات العامّة لسرطان الرئة المحدث بواسطة دخان التبغ :
Lung Cancer Pathways
مناقشة المكونات كل على حدى
1. النيكوتين
المسرطنات
4. متراكبات الدنا DNA Adduct
5.تبعات تشكل متراكبات الدنا DNA
6. المحددات الحيوية Biomarkers
Conclusion
نتائج مدمرة على صعيد الصحة الشخصية –سرطان الرئة- قد تنتهي بالموت
تم إيضاح آلية حدوث السرطان بشكل جيد في سرطان الرئة ولكن دور العديد من المواد لم يحدد بشكل دقيق بعد (متراكبات الدنا, دور المواد غير السامة جيناً...)
فهم أفضل للسرطان – وقاية أفضل.
كيف تحمي نفسك من الهجوم الكيمائي؟
الهجوم الكيمائي- السارين
ماهو السارين:
سلاح قوي جداً للحرب الكيماوية يستخدم في الحروب كسم للأعصاب وينتمي إلى زمرة الفوسفات العضوية, يؤدي في الجسم إلى تعطيل إشارات إيقاف التقلص العضلي و بالتالي يؤدي إلى تقلص مستمر (تشنج مستمر) و الخطورة تكمن في توقف العضلات التنفسية عن العمل.
متى استخدم غاز السارين:
كيف يتعرض الناس للسارين؟
ما هي المدة اللازمة لظهور الأعراض على المصابين:
الأعراض و العلامات الفوري/ة التي تظهر على المصاب:
خطوات العلاج:
التصنيف
المرادفات والأسماء الشائعة
نبذة تاريخية
المواد الفعالة
دليل الجرعات
محاذير الاستخدام
ملاحظات حول الاستخدام
وصف النبات
القسم المستعمل
المكونات
المواد الفعالة
0.1 What are viruses?
1. Origin of viruses
1.1 introduction
1.2 Theories
RNA molecules that existed before cells
cell components
micro-organisms.
1.3 Conclusion: How did viruses originate?
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
2. What’s a suspension ?
• Defintion
• Dimentions(0.5-10) (1-10) (10-50)
• Good Suspension (10-50), Why?
• Both kinds:
o Oral Suspensions
o For Oral Suspension
Why called dry syrups?
5. Why a suspension?
•Advantages
• Liquid Therapy!
• What about Chemical Stability?
• What about (infants, children, and the elderly) ?
• What about taste?
6. Why a suspension?
•Disadvantages
• What about stability and skills required?
• What about shelf-time?
• Appearapnce ?
• Carry with pateint?
• Note that:, erythromycin estolate
8. Stability;
• So it’s an Indication
• Dicussing all factors affecting the stability, including:
• Particle size
• Density (floating vs. sedimentation)
• Viscosity
• Note that: It’s not appropriate to a
suspension to float??
• It’s not appropriate to have too
much fine powders??
9. HOW TO MAKE A FINE
POWDER? (10-50 MICRON)
• Micropulverization?---attrition mills
• Still finer powder? Fluid energy, what size?
• How?
• high-velocity compressed airstreams.
• confined space!
13. Preparing Flocculated
suspensions
• Definition
• less rigid or loose aggregation!!
• flocs settle more rapidly than fine ????
• weak particle-to-particle bonds
• higher sediment volume
• distribute readily
14. Preparing Flocculated
suspensions
• diluted bentonite magma.
flocculating agent
• pH: minimum solubility
• Electrolytes can also act as
flocculating agents
• The carefully determined
concentration of non-ionic and
ionic surface-active agents
(surfactants) can also induce
flocculation
15. Formulationconsiderationsfor orally
administeredsuspension:
• Physical properties of the therapeutic Agent:
• Particle size
• Crystallisation
• Hydrophilic polymers to solve the proplem.
• Particle Shape:
• i.e.: The needle-shaped particles formed a tenacious sediment cake on standing
that could not be redistributed, whereas the barrel-shaped particles did not cake
upon standing.
28. Excipients used in the formulationof
suspensions for oral administration:
• Vehicle:
• Most common is
• It is prepared by distillation, ion exchange methods or by
reverse osmosis
• i.e.: Citric/Citrate of veicles:
• Acidity, Alkanity? Electrolytes? Taste?
• Our product. Citric/citrate which lead to pH=5.5
• Although it’s not the appropriate to minimum stability
29. Excipients used in the formulationof
suspensions for oral administration:
30. Excipients used in the formulationof
suspensions for oral administration:
Note that: a liquid suspension for a neonate should
not include preservatives, colorings, flavorings, or
alcohol because of the potential for each of these to
cause either acute or long-term adverse effects.
31. Excipients used in the formulationof
suspensions for oral administration:
• ExcipientstoenhancethephysicalstabilityofSuspensions:
• Addition of electrolytes
• (Brownian, Steric, and Electrostatic vs. Vandeer Vals)
32. Excipients used in the formulationof
suspensions for oral administration:
33. Excipients used in the formulationof
suspensions for oral administration:
• Surface-active agents:
• Effect on wetting
34. Excipients used in the formulationof
suspensions for oral administration:
• Effect on flocculation
• ionic or non-ionic polymers? And why?
• Consider oral preps and Safety.
•
e.g. polyoxyethylene fatty acid sorbitan esters, sorbitan esters or lecithin
35.
36. Excipients used in the formulationof
suspensions for oral administration:
• Effectsonthephysicalstabilityofsuspensions:
stearic repulsion
37. Polymer Distance
•NoteThat:
• It reduces repulsion on far distance (stearic repulsion) but
enhance it on far distance (reduces zeta potential)
• Next example clarifies the idea.
38. Excipients used in the formulationof
suspensions for oral administration:
• Polymer Effect depends on the following:
• Concentration:
• enhances repulsion but does not prevent the interaction of the
particles in the secondary minimum
39. Excipients used in the formulationof
suspensions for oral administration:
• Polymer Effect depends on the following:
• The type of polymer:
• This ability to interact may effectively maintain the polymer-coated
particles at a distance, resulting in the production of a structured
floccule
stearic repulsion
40. Excipients used in the formulationof
suspensions for oral administration:
• Polymer Effect depends on the following:
• Effect on the rheological properties of oral suspension:
• concentrations ˃0.01%: (oral suspensions)
• Pseudoplatic system -thixotropy
41. Excipients used in the formulationof
suspensions for oral administration:
• Examples:
• MC, HEC, HPMC, sodium CMC
• Polyvinylpyrrolidone
• Acacia, tragacanth and xanthan (caution)
• Bentonite
44. Excipients used in the formulationof
suspensions for oral administration:
• Preservatives and mold growth:
• Is the mold growth allowed?
• How much?
• What’s prevented?
• Examples
45. Excipients used in the formulationof
suspensions for oral administration:
• Sweetening agents/flavours
• Compliance?
• aesthetic properties?
• i.e.: sorbitol
• Antioxidants
• Stability?
■ i.e: sodium sulphite
46. Some subdosage forms of
suspensions
• DRY POWDERS FOR SUSPENSIONS:
• i.e.:Antibacterial , stability?
• Antacid Oral Suspensions
• RECTAL SUSPENSIONS.
• Antibacterial Oral Suspensions
47. Some subdosage forms of
suspensions
Sustained-Release Suspensions (Pennkinetic):
48. Some subdosage forms of
suspensions
Sustained-Release Suspensions (Pennkinetic):